Format
Sort by

Send to

Choose Destination

Selected items

Items: 3

1.

Technology evaluation: AAV factor IX gene therapy, Avigen Inc.

Fabb SA, Dickson JG.

Curr Opin Mol Ther. 2000 Oct;2(5):601-6. Review.

PMID:
11249763
2.

Neuropathic pain treatment gives Avigen new lease on life and Neuromed follows the snail trail.

Wolfson W.

Chem Biol. 2007 Apr;14(4):341-3. No abstract available. Erratum in: Chem Biol. 2007 May;14(5):601.

3.

Avigen AAV trial continues.

Bouchie A.

Nat Biotechnol. 2002 Feb;20(2):109. No abstract available.

PMID:
11845795

Supplemental Content

Support Center